Press Release: NEUROPA initiative receives €3.6 million to develop new theranostic for the brain
Updated: Feb 21
The NEUROPA initiative targets a transformative progress in photonics, neuroscience and medicine by developing a non-invasive means of modulating specific neural pathways in the brain.
This research, led by Aston University, is a collaboration between University of Bayreuth. (DE), University of Oulu (Finland), University of Barcelona (Spain), Pharmacoidea (Hungary), Sorbonne University (France) and DLM Consultancy Services Ltd (UK). The project is funded by the European Commission through its Future and Emerging Technology (Open) programme The NEUROPA project is headed by Professor Edik Railov, Aston Institute of Photonic Technologies
The NEUROPA consortium, led by Aston University, has received a prestigious award of €3.6 million in funding from the European Commission as part of its Future and Emerging Technology (FET) scheme. The project aims to develop a non-invasive means of alleviating long-term dysfunction in the brain addressing specific brain disorders such as Huntingdon’s (HD) and cognitive impairment in Alzheimer’s (AD).